NewBridge Pharmaceuticals Forms Partnership With Genomic Health to Bring Novel Genomic Testing to Patients in Middle East, Africa, and Caspian Regions
DUBAI, UNITED ARAB EMIRATES -- (Marketwire) -- 08/13/12 -- NewBridge Pharmaceuticals, a specialty therapeutics company focused on pharmaceuticals, biologics, diagnostics and medical devices serving the AfMET region (Middle East, Africa, Turkey & Caspian regions), today announced that the company has established an exclusive agreement with Genomic Health, Inc. (NASDAQ: GHDX), a global health company that provides actionable genomic information to personalize genomic health decisions, to provide the Oncotype DX® test in the NewBridge's core strategic territoriesin the Middle East, Africa, and Caspian regions. As part of this agreement, NewBridge will be able to offer the Oncotype DX tests for treatment of patients with early-stage, estrogen-positive (ER+) invasive breast cancer, DCIS (ductal carcinoma in situ of the breast), as well as colon cancer patients with stage II and stage III disease.
management wants to promote the science.The Baker Brothers want to make money.For the past 5 of 7 years Insiders owned the company and guided the science.For the past 2 bigger money has gained control.Please dont say big money cares for they ALWAYS have the supreme decider on the top of their list.
Of course, if the Bakers want to go this way, there is little we can do about it. I don't begrudge their success. If I could, I'd do the same thing.
>>And I will sell today at 40, so go ahead and take it private at that price for all I care.<<
We have different investment styles. I do best identifying a handful of companies that have a good chance of quadrupling in several years and holding. I know biotech so that is what I research. Over the years the most frustrating problem has been the company selling itself too early. I might get a double and the board and management get taken care of while the products go on to make some major pharma big bucks.
Genomic Health is way ahead of the competition in this field. I have no worries regarding their patents. They have plenty of cash and don't lose money. If they can stay the course without selling out I'm pretty sure they'd be worth five times the current cap in four to five years. Quest and others need to expand in this direction as their business is increasingly commoditized.
Don't let the Bakers buy you out for 40 bucks, buy the board out for a million in shares, and promise management golden positions just so they can package the company a few years later for much more. Their patience is why they are wealthy. Be patient too.
RE: "How do these 2 venture capitalists who own 40% of this company sit on the BOD? conflict of interest?"
Absolutely not.....heavily investors stakeholders is preferable to disinterested outsiders who may be pawns for upper management. You should have no doubt in your mind that the Baker Bros have the best interests of shareholders in mind.....too many companies failed over the last few years partly due to disinterested cronie directors simply cashing checks and acting as pawns for upper mgmt......certainly not the case here....
and I think you could add a little more than just "venture capitalists" to a description of the Bakers....